Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
about
Basic mechanisms of rTMS: Implications in Parkinson's diseaseMapping track density changes in nigrostriatal and extranigral pathways in Parkinson's diseaseDJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2The role of oxidative stress in Parkinson's diseaseThe Preclinical Research Progress of Stem Cells Therapy in Parkinson's DiseaseStructural Neuroimaging Markers of Cognitive Decline in Parkinson's DiseaseWhat can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseNeuroimaging studies of the striatum in cognition Part I: healthy individualsNeuroimaging studies of striatum in cognition part II: Parkinson's diseaseCatecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersThe role of the basal ganglia in learning and memory: insight from Parkinson's diseaseCalcium, bioenergetics, and neuronal vulnerability in Parkinson's diseasePreservation of function in Parkinson's disease: what's learning got to do with it?Upstream deregulation of calcium signaling in Parkinson's diseaseReward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s diseaseLevodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian ratsExploring Biological Motion Processing in Parkinson's Disease Using Temporal DilationGray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's DiseaseMolecular imaging of movement disordersHow compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatumThe Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's DiseaseParkinson's disease as a result of agingBrasofensine treatment for Parkinson's disease in combination with levodopa/carbidopaThe locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural studyElevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRSThe role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned ratsEncoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.Individual differences in beat perception affect gait responses to low- and high-groove music.The effect of Parkinson's disease on interference control during action selection.On the Complexity of Brain Disorders: A Symptom-Based Approach.Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.Dose dependent dopaminergic modulation of reward-based learning in Parkinson's diseaseGray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease.The risky business of dopamine agonists in Parkinson disease and impulse control disorders.Implicit sequence learning in people with Parkinson's disease.Clinical applications of mesenchymal stem cells in chronic diseases.The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease.Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia.Automated quantitative gait analysis in animal models of movement disorders.
P2860
Q21202047-62521F43-DC8E-4234-AE26-D988A7C6646FQ24040262-0131A9AA-B2B2-4FFF-8660-F7C128F768A9Q24305442-D939A4ED-93BE-44EB-AFE7-7019880DDD0AQ24307946-E7338569-33C6-46B2-A5E5-A7A7F7DCDFBBQ26744445-5D3DBA5C-87EF-4ED6-88E7-F78745EE22D7Q26748709-AA622AD7-E955-493E-83F6-3E2106E359BEQ26767268-4346F6D7-C2C8-4725-A4D2-1FB14D975626Q26773485-60AD9EEA-8E77-40FD-8795-C0C26D4B9F16Q26779302-5FB4B13B-31FF-4530-8AD7-D686D7C8E06FQ26779306-AA6B8E73-7E09-4CAB-8848-248A724F6C95Q26826093-141A3991-3CA1-4865-9ABA-25A76E8DE6FDQ26851807-BD5E0093-E368-403C-A00E-EEE66C5B61E3Q26853225-8D067A5D-2E0F-4A11-A5F7-88E4AE598F41Q26853387-1F27C76F-7441-4A27-B221-D5FEF63B7DEFQ27026384-82AED166-9B34-45F0-80BC-99284F52F251Q27303483-E0CCF27D-5FDD-4DBE-8626-0199BFC4E374Q27316872-76D88443-4562-4497-95C5-8F078D65276CQ27316956-B6F592C2-561B-4DF3-8A76-BB43EE05667AQ27327538-9689CF49-05D3-401A-B6AB-FE9CBC2159FBQ28071336-AD709604-1EA2-4540-AAC9-391BC91FBFE8Q28078491-6E7E7507-B611-4B50-B8C2-0E9B21A5375BQ28078546-303313FF-E8E5-4B2C-9154-DDC2E6F96B72Q28084395-875BE28F-4999-49D6-BE85-61B726C6D1F7Q28201762-86D99E43-0536-4B1D-A2B5-312CA62B285FQ28477041-0F36D9A7-E9D3-4C4B-8CD3-6494724E4882Q28479192-B0455CE5-186D-4755-9AFC-F876053E6F93Q28482094-E6D29675-F8F1-41D8-9901-43A896D66B8DQ30364799-13FBB292-B286-4100-993F-C46B144A9924Q30368420-EB8D4F4C-DAB7-4C6A-A3A6-0D65199B23A2Q30371505-54148D68-0DC7-4A04-925E-4D54112893C9Q30389213-3F909182-8941-48B8-ACC7-08406C915CFCQ30394681-45FEDE4A-6C7E-461B-B152-8C7310D99DD9Q30418659-C8071B52-FB65-4F8F-84AC-F3453E8D59F4Q30421996-095C9D98-8AC7-47E9-99CD-DE89453CCD4CQ30425695-E53427B0-92A4-4D62-A4B9-C159078B4713Q30432855-B56A80BB-5691-4E86-8232-B3F156659BBDQ30437823-BAE4A382-FD0E-4AA1-B0CF-BFD5E07B3D91Q30443884-65D62EA1-540C-47E5-ADA1-8B10600F647CQ30483340-1F30DA61-F08F-46A2-AB4C-F8C4149C767BQ30496179-848C9E62-4668-480D-B78B-8C76D99F67EC
P2860
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Uneven pattern of dopamine los ...... gic and clinical implications.
@en
Uneven pattern of dopamine los ...... gic and clinical implications.
@nl
type
label
Uneven pattern of dopamine los ...... gic and clinical implications.
@en
Uneven pattern of dopamine los ...... gic and clinical implications.
@nl
prefLabel
Uneven pattern of dopamine los ...... gic and clinical implications.
@en
Uneven pattern of dopamine los ...... gic and clinical implications.
@nl
P2093
P921
P1476
Uneven pattern of dopamine los ...... gic and clinical implications.
@en
P2093
Hornykiewicz O
P304
P356
10.1056/NEJM198804073181402
P407
P577
1988-04-01T00:00:00Z